RHUDEX
Dead / Cancelled — Cancelled — Section 8 (as of 06 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88245830
- Registration number
- 5812401
- Mark type
- Stylized text
- Filed
- 31 Dec 2018
- Published for opposition
- 07 May 2019
- Registered
- 23 Jul 2019
- Attorney of record
- David A. Bell
Goods and services
- Class 005 — Pharmaceuticals: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
- Class 010 — Medical apparatus: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes
- Class 042 — Scientific and technological services: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology
Owner
- Medigene AG, Planegg-Martinsried, DE
- Medigene AG, Planegg-Martinsried, DE
- Medigene AG, Planegg-Martinsried, DE
Prior registrations
Prosecution history
- 06 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 23 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2019 — PUBLISHED FOR OPPOSITION
- 17 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2019 — EXAMINER'S AMENDMENT ENTERED
- 22 Mar 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Mar 2019 — EXAMINERS AMENDMENT E-MAILED
- 22 Mar 2019 — EXAMINERS AMENDMENT -WRITTEN
- 20 Mar 2019 — ASSIGNED TO EXAMINER
- 20 Mar 2019 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 11 Mar 2019 — ASSIGNED TO LIE
- 08 Mar 2019 — TEAS VOLUNTARY AMENDMENT RECEIVED